LEUTX
gene geneOn this page
Summary
LEUTX (leucine twenty homeobox, HGNC:31953) is a protein-coding gene on chromosome 19q13.2, encoding Paired-like homeodomain transcription factor LEUTX (A8MZ59). Paired-like homeobox transcription factor involved in embryogenesis.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 342900 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 24 total
- GTEx eGene: eQTL in 1 tissue, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.05 (LoF-tolerant), LOEUF 1.84 (unconstrained)
- MANE Select transcript:
NM_001382345
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31953 |
| Approved symbol | LEUTX |
| Name | leucine twenty homeobox |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000213921 |
| Ensembl biotype | protein_coding |
| OMIM | 618701 |
| Entrez | 342900 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
MANE Select: ENST00000638280
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 2: 1, TSL 3: 1
ENST00000638280, ENST00000396841
RefSeq mRNA: 2 — MANE Select: NM_001382345
NM_001143832, NM_001382345
CCDS: CCDS92615
Canonical transcript exons
ENST00000638280 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003803257 | 39785698 | 39786291 |
| ENSE00003806262 | 39778854 | 39778927 |
| ENSE00003810096 | 39784527 | 39784678 |
Expression profiles
Bgee: expression breadth tissue_specific, 9 present calls, max score 97.16.
Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, colonic epithelium, ventricular zone, cortical plate.
Genetic regulation across tissues (GTEx eQTL / sQTL)
LEUTX is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 1 tissue and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
1 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Cells EBV-transformed lymphocytes | eqtl | 1.1e-07 | +0.42 | 19:39784269:G:A |
Top tissues by expression
showing 100 of 125 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 52.61 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 29.47 | silver quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| placenta | UBERON:0001987 | 28.66 | silver quality |
| monocyte | CL:0000576 | 28.39 | silver quality |
| leukocyte | CL:0000738 | 28.32 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.00 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| muscle of leg | UBERON:0001383 | 24.98 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| pancreas | UBERON:0001264 | 24.17 | gold quality |
| rectum | UBERON:0001052 | 24.16 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| gastrocnemius | UBERON:0001388 | 23.78 | gold quality |
| frontal cortex | UBERON:0001870 | 23.74 | gold quality |
| kidney | UBERON:0002113 | 23.19 | gold quality |
| calcaneal tendon | UBERON:0003701 | 23.08 | gold quality |
| endometrium | UBERON:0001295 | 22.90 | gold quality |
| right lobe of liver | UBERON:0001114 | 22.36 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 22.15 | gold quality |
| heart left ventricle | UBERON:0002084 | 22.01 | gold quality |
| cortex of kidney | UBERON:0001225 | 21.85 | gold quality |
| myometrium | UBERON:0001296 | 21.65 | gold quality |
| body of pancreas | UBERON:0001150 | 21.36 | gold quality |
| heart | UBERON:0000948 | 21.24 | gold quality |
| tibial artery | UBERON:0007610 | 21.20 | gold quality |
| popliteal artery | UBERON:0002250 | 21.19 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 21.10 | gold quality |
| uterine cervix | UBERON:0000002 | 20.73 | gold quality |
| granulocyte | CL:0000094 | 20.63 | gold quality |
| stomach | UBERON:0000945 | 20.58 | gold quality |
| esophagus mucosa | UBERON:0002469 | 20.44 | gold quality |
| esophagus | UBERON:0001043 | 20.30 | gold quality |
| apex of heart | UBERON:0002098 | 20.28 | gold quality |
| multicellular organism | UBERON:0000468 | 19.92 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 19.91 | gold quality |
| lung | UBERON:0002048 | 19.71 | gold quality |
| right atrium auricular region | UBERON:0006631 | 19.63 | gold quality |
| thoracic aorta | UBERON:0001515 | 19.54 | gold quality |
| ascending aorta | UBERON:0001496 | 19.53 | gold quality |
| body of stomach | UBERON:0001161 | 19.46 | gold quality |
| intestine | UBERON:0000160 | 19.45 | gold quality |
| colon | UBERON:0001155 | 19.43 | gold quality |
| right coronary artery | UBERON:0001625 | 19.38 | gold quality |
| lower esophagus | UBERON:0013473 | 19.30 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 19.28 | gold quality |
| cerebellum | UBERON:0002037 | 19.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 19.13 | gold quality |
| small intestine | UBERON:0002108 | 19.12 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 19.04 | gold quality |
| left coronary artery | UBERON:0001626 | 19.00 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 18.95 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 18.89 | gold quality |
| fundus of stomach | UBERON:0001160 | 18.84 | gold quality |
| ovary | UBERON:0000992 | 18.79 | gold quality |
| transverse colon | UBERON:0001157 | 18.76 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 18.68 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 18.64 | gold quality |
| right adrenal gland | UBERON:0001233 | 18.63 | gold quality |
| Ammon’s horn | UBERON:0001954 | 18.62 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 18.55 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 18.53 | gold quality |
| adipose tissue | UBERON:0001013 | 18.51 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 18.47 | gold quality |
| fallopian tube | UBERON:0003889 | 18.43 | gold quality |
| putamen | UBERON:0001874 | 18.37 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 18.35 | gold quality |
| mucosa of stomach | UBERON:0001199 | 18.29 | gold quality |
| adrenal tissue | UBERON:0018303 | 18.25 | gold quality |
| omental fat pad | UBERON:0010414 | 18.23 | gold quality |
| temporal lobe | UBERON:0001871 | 18.21 | gold quality |
| prostate gland | UBERON:0002367 | 18.13 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 18.12 | gold quality |
| amygdala | UBERON:0001876 | 17.98 | gold quality |
| zone of skin | UBERON:0000014 | 17.92 | gold quality |
| substantia nigra | UBERON:0002038 | 17.91 | gold quality |
| left ovary | UBERON:0002119 | 17.78 | gold quality |
| nucleus accumbens | UBERON:0001882 | 17.75 | gold quality |
| skin of abdomen | UBERON:0001416 | 17.70 | gold quality |
| skin of leg | UBERON:0001511 | 17.70 | gold quality |
| minor salivary gland | UBERON:0001830 | 17.60 | gold quality |
| ectocervix | UBERON:0012249 | 17.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
HPA expression
RNA tissue specificity: Not detected
28 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Cerebellum | tissue | 8.9 |
| Olfactory bulb | tissue | 6.2 |
| Amygdala | tissue | 5.3 |
| Cerebral cortex | tissue | 5.0 |
| Basal ganglia | tissue | 5.0 |
| Corpus callosum | tissue | 5.0 |
| Occipital cortex | tissue | 5.0 |
| Insular cortex | tissue | 4.7 |
| Ventral pallidum | tissue | 4.6 |
| Cingulate cortex | tissue | 4.6 |
| Prefrontal cortex | tissue | 4.5 |
| Somatosensory cortex | tissue | 4.4 |
| Temporal cortex | tissue | 4.4 |
| Hippocampal formation | tissue | 4.3 |
| Entorhinal cortex | tissue | 4.3 |
| Retrosplenial cortex | tissue | 4.2 |
| Motor cortex | tissue | 4.1 |
| Substantia nigra | tissue | 3.7 |
| Putamen | tissue | 3.6 |
| Medulla oblongata | tissue | 3.1 |
| Periaqueductal gray | tissue | 3.0 |
| Hypothalamus | tissue | 2.8 |
| Spinal cord | tissue | 2.7 |
| Septum | tissue | 2.7 |
| Midbrain | tissue | 2.6 |
| Superior colliculi | tissue | 2.3 |
| Pons | tissue | 2.2 |
| Thalamus | tissue | 1.7 |
Brain sub-regions (HPA Brain Atlas): detected in 6; highest nTPM — White matter (5.0), Dorsal hippocampus (4.2), Ventral hippocampus (3.9), Subiculum (3.4), Ventral spinal cord (2.7).
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2597.1 | LEUTX | Paired-related HD |
JASPAR matrix evidence (PMIDs): PMID:27578796
Functional genomics
gnomAD constraint: pLI 0.0455, LOEUF 1.84, missense Z 0.273 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000638280 — one region, missense o/e 0.97.
Literature-anchored findings (GeneRIF, showing 2)
- Rapid Evolution of the Embryonically Expressed Homeobox Gene LEUTX within Primates. (PMID:37232378)
- Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion. (PMID:38500181)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | Dbx | FBGN0261723 |
Paralogs (3): DBX1 (ENSG00000109851), HLX (ENSG00000136630), DBX2 (ENSG00000185610)
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Encephalitozoon cuniculi GB-M1 | Q8SW51 | 46.0% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| FBL | protein-coding | 2091 |
| FCGBP | protein-coding | 8857 |
| DYRK1B | protein-coding | 9149 |
| LGALS14 | protein-coding | 56891 |
| MIR6719 | ncRNA | 102465974 |
| CLC | protein-coding | 1178 |
Protein
Protein identifiers
Paired-like homeodomain transcription factor LEUTX — A8MZ59 (reviewed: A8MZ59)
Alternative names: Leucine-twenty homeobox, Paired-like homeobox transcription factor LEUTX
All UniProt accessions (1): A8MZ59
UniProt curated annotations — full annotation on UniProt →
Function. Paired-like homeobox transcription factor involved in embryogenesis. May act as a regulator of embryo genome activation. Binds to a 36 bp DNA elements containing a 5’-TAATCC-3’ sequence motif, referred to as EEA motif (EGA-enriched Alu-motif), present in the promoters of target genes activated in early embryos. Inactive transcriptional activity.
Subcellular location. Nucleus.
Domain organisation. The homeobox contain essential residues (Ile-54, Lys-57, Ala-61) for binding to the 5’-TAATCC-3’ motif of the targe gene promoters. The homeobox is incomplete and cannot bind to the 36 bp motif found in the promoters of the target genes. The 9aaTAD motif is a conserved putative nine amino acid transactivation motifs in C-terminus of the LEUTX region.
Similarity. Belongs to the paired homeobox family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A8MZ59-2 | 1, LEUTX.n | yes |
| A8MZ59-1 | 2, LEUTX.R |
RefSeq proteins (2): NP_001137304, NP_001369274* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
Pfam: PF00046
UniProt features (17 total): short sequence motif 4, site 3, mutagenesis site 2, sequence conflict 2, region of interest 2, chain 1, DNA-binding region 1, splice variant 1, compositionally biased region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MZ59-F1 | 68.84 | 0.29 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Transcription factors, Helix-turn-helix domains
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): nucleoli; nucleoplasm
Antibody reliability (HPA): IH uncertain · IF approved
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3)
| Position | Role |
|---|---|
| 57 | required for binding to the 5’-taatcc-3’ sequence |
| 61 | required for binding to the 5’-taatcc-3’ sequence |
| 54 | required for binding to the 5’-taatcc-3’ sequence |
Mutagenesis-validated functional residues (2)
| Position | Phenotype |
|---|---|
| 54 | increased transcriptional activity; when associated with ala-61-val, restores wild-type transcriptional activity. |
| 61 | abolished catalytic activity; when associated with ile-54-thr, restores wild-type transcriptional activity. |
Function
Pathways and Gene Ontology
Reactome pathways
1 curated (TAS) of 3; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
3 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-9819196 | Zygotic genome activation (ZGA) | curated |
| R-HSA-1266738 | Developmental Biology | — |
| R-HSA-9816359 | Maternal to zygotic transition (MZT) | — |
MSigDB gene sets: 14 (showing top):
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, WP_PREIMPLANTATION_EMBRYO, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT, REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA, PULVER_FOREY_PERTURB_ATTRITION_S, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, chr19q13, GOCC_CHROMATIN, FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP, FLORIO_HUMAN_NEOCORTEX
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654)
Reactome top-level categories
2 top-level categories:
| Category | Pathways |
|---|---|
| Maternal to zygotic transition (MZT) | 1 |
| Developmental Biology | 1 |
GO top-level categories
16 GO namespaces:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
Protein interactions and networks
STRING
showing 15 of 444 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LEUTX | DPRX | A6NFQ7 | 807 |
| LEUTX | DUXB | A0A1W2PPF3 | 756 |
| LEUTX | DUX4L2 | P0CJ85 | 750 |
| LEUTX | TPRX1 | Q8N7U7 | 747 |
| LEUTX | KHDC1L | Q5JSQ8 | 739 |
| LEUTX | DUXA | A6NLW8 | 734 |
| LEUTX | TRIM43 | Q96BQ3 | 702 |
| LEUTX | PRAMEF1 | O95521 | 677 |
| LEUTX | ZSCAN4 | Q8NAM6 | 659 |
| LEUTX | MBD3L2 | Q8NHZ7 | 655 |
| LEUTX | KHDC1 | Q4VXA5 | 630 |
| LEUTX | NUTM2A | Q8IVF1 | 606 |
| LEUTX | PRAMEF2 | O60811 | 570 |
| LEUTX | MBD3L3 | A6NE82 | 550 |
| LEUTX | NUTM1 | Q86Y26 | 548 |
IntAct
Human interaction partners of LEUTX in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
showing 30 of 45 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| AGPAT4 | physical association | 0.560 | 3 |
| AIG1 | physical association | 0.560 | 3 |
| AQP2 | physical association | 0.560 | 3 |
| AQP3 | physical association | 0.560 | 3 |
| ASGR1 | physical association | 0.560 | 3 |
| C1QL4 | physical association | 0.560 | 3 |
| CDS2 | physical association | 0.560 | 3 |
| CMTM3 | physical association | 0.560 | 3 |
| CMTM5 | physical association | 0.560 | 3 |
| CNIH1 | physical association | 0.560 | 3 |
| CNIH3 | physical association | 0.560 | 3 |
| CXCL9 | physical association | 0.560 | 3 |
| EMP3 | physical association | 0.560 | 3 |
| ENTPD3 | physical association | 0.560 | 3 |
| FAM24B | physical association | 0.560 | 3 |
| FZD7 | physical association | 0.560 | 3 |
| GOSR2 | physical association | 0.560 | 3 |
| KIR2DL3 | physical association | 0.560 | 3 |
| LAT | physical association | 0.560 | 3 |
| MRPL57 | physical association | 0.560 | 3 |
| MS4A1 | physical association | 0.560 | 3 |
| NAPB | physical association | 0.560 | 3 |
| NDRG4 | physical association | 0.560 | 3 |
| OLFM4 | physical association | 0.560 | 3 |
| PLP1 | physical association | 0.560 | 3 |
| PNLIPRP1 | physical association | 0.560 | 3 |
| PRB1 | physical association | 0.560 | 3 |
| SLC13A3 | physical association | 0.560 | 3 |
| SLC30A8 | physical association | 0.560 | 3 |
| SLC41A2 | physical association | 0.560 | 3 |
BioGRID (47 interactions; top human partners by supporting records): AGPAT4 (Two-hybrid), AIG1 (Two-hybrid), AQP2 (Two-hybrid), AQP3 (Two-hybrid), ASGR1 (Two-hybrid), C1GALT1 (Two-hybrid), C1QL4 (Two-hybrid), C3orf52 (Two-hybrid), CDS2 (Two-hybrid), CMTM3 (Two-hybrid), CMTM5 (Two-hybrid), CNIH1 (Two-hybrid), CNIH3 (Two-hybrid), CXCL9 (Two-hybrid), EMP3 (Two-hybrid)
Disease & clinical
Genetic variants
Variant evidence for LEUTX: 24 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 3 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 30 predictions of 216):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 19:39785696–39785697 | acceptor_loss | 1.0000 | 5 |
| 19:39778928–39778929 | donor_loss | 0.9900 | 5 |
| 19:39784652 | donor_gain | 0.9900 | |
| 19:39785697 | acceptor_loss | 0.9800 | |
| 19:39784525–39784526 | acceptor_loss | 0.9600 | 6 |
| 19:39784511 | acceptor_loss | 0.9400 | |
| 19:39784313 | donor_gain | 0.9300 | |
| 19:39784513 | acceptor_loss | 0.9300 | |
| 19:39784679–39784680 | donor_loss | 0.9300 | 5 |
| 19:39784678–39784680 | donor_loss | 0.9200 | 4 |
AlphaMissense
178 missense substitutions predicted likely pathogenic (of 1,279 scored), across 47 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| N58 | 8 | 0.935 | 0.973 |
| F56 | 7 | 0.961 | 0.991 |
| W55 | 7 | 0.897 | 0.946 |
| F15 | 7 | 0.896 | 0.972 |
| D48 | 7 | 0.689 | 0.875 |
| K57 | 6 | 0.884 | 0.981 |
| P33 | 6 | 0.861 | 0.951 |
| R12 | 6 | 0.838 | 0.929 |
| Q19 | 6 | 0.830 | 0.901 |
| K62 | 6 | 0.793 | 0.923 |
| T13 | 6 | 0.727 | 0.901 |
| K53 | 5 | 0.795 | 0.907 |
| V52 | 5 | 0.780 | 0.924 |
| L23 | 5 | 0.737 | 0.965 |
| A42 | 4 | 0.856 | 0.965 |
| L47 | 4 | 0.834 | 0.920 |
| Q59 | 4 | 0.791 | 0.946 |
| V51 | 4 | 0.752 | 0.815 |
| W155 | 4 | 0.748 | 0.793 |
| S34 | 4 | 0.731 | 0.739 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene MIM:618701 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST006976_86 | Macular thickness | 5e-17 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.